Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001514179 | SCV001721960 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001514179 | SCV001983904 | likely benign | not provided | 2021-04-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446680 | SCV004172145 | benign | Retinitis pigmentosa 39 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001279665 | SCV004172146 | benign | Usher syndrome type 2A | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001279665 | SCV001466779 | benign | Usher syndrome type 2A | 2020-07-19 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004538556 | SCV004748976 | benign | USH2A-related disorder | 2019-08-02 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |